Cognitive function in congenital adrenal hyperplasia

Endocrinology and Metabolism Clinics of North America
Sheri A Berenbaum

Abstract

Cognition in patients with CAH has not been as well studied as other aspects of psychologic function. Nevertheless, it is possible to make some conclusions and to offer a number of hypotheses for further study (Table 1). First, patients with CAH do not seem to have an overall intellectual advantage as a direct consequence of the disease. The high IQs reported in some groups of patients with CAH are also reported in their siblings and probably reflect sampling bias. Second, it is possible that, on average, patients with salt-wasting CAH have lower overall ability than patients with the simple-virilizing form, but both groups are well within the normal range, and there is considerable variability among both groups. Third, the evidence to date does not confirm that patients with CAH are more likely to have diagnosable learning disabilities when compared with their unaffected relatives, but this issue has not been well studied with the appropriate psychoeducational assessments. It is unlikely that patients with CAH are at substantially increased risk for frank learning disabilities, but they may be likely to have problems in specific areas. Fourth, females with CAH seem to have enhanced spatial ability as a result of exposure to hi...Continue Reading

References

Apr 1, 1975·Behavior Genetics·L S McGuire, G S Omenn
Apr 1, 1975·Behavior Genetics·L S McGuireG S Omenn
Oct 1, 1991·Journal of Child Neurology·R Nass, S Baker
Jan 1, 1991·Psychoneuroendocrinology·C L Williams, W H Meck
Jan 1, 1991·Psychoneuroendocrinology·J Bachevalier, C Hagger
Jan 1, 1991·Psychoneuroendocrinology·R Nass, S Baker
Aug 22, 1990·JAMA : the Journal of the American Medical Association·S E ShaywitzM D Escobar
Jan 1, 1986·Neuropsychobiology·J BornK H Voigt
Oct 1, 1987·Journal of Consulting and Clinical Psychology·T E Moffitt, P A Silva
Oct 14, 1982·The New England Journal of Medicine·D Rodbard, H Wachslight-Rodbard
Jun 25, 1982·Science·C DeLacoste-Utamsing, R L Holloway
Dec 1, 1980·Hormones and Behavior·S D Holman, R W Goy
Mar 1, 1994·Archives of Disease in Childhood·M D DonaldsonD C Savage
Aug 9, 1996·Science·R M Sapolsky
Feb 1, 1997·Archives of Neurology·J HarastyD A McRitchie
Dec 1, 1996·Hormones and Behavior·K J ZuckerJ Hood
Jun 1, 1997·Brain Research. Brain Research Reviews·S J Lupien, B S McEwen
Nov 28, 1997·Psychoneuroendocrinology·S A Berenbaum, S M Resnick
Apr 15, 1999·Annual Review of Neuroscience·B S McEwen
Sep 11, 1999·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·E S BrownB S McEwen
Oct 3, 1999·Progress in Cardiovascular Diseases·L Resnick
Mar 31, 2000·Brain and Cognition·D F Halpern
May 10, 2001·Endocrinology and Metabolism Clinics of North America·H F Meyer-Bahlburg
Oct 13, 2001·Hormone Research·J W Honour, T Torresani
Jan 1, 1993·European Child & Adolescent Psychiatry·R W DittmannM E Kappes

❮ Previous
Next ❯

Citations

Feb 1, 2012·Behavioral Neuroscience·Sheri A BerenbaumAdriene M Beltz
Oct 27, 2010·International Journal of Pediatric Endocrinology·Sheri A BerenbaumStephen C Duck
Jan 7, 2006·Hormone Research·Judith RossAndrew Zinn
Mar 8, 2008·The Journal of Clinical Endocrinology and Metabolism·Deborah P Merke
Aug 15, 2002·American Journal of Pharmacogenomics : Genomics-related Research in Drug Development and Clinical Practice·P W Speiser
Nov 22, 2001·Journal of Endocrinological Investigation·P W Speiser
May 25, 2005·Developmental Psychology·Rebecca Christine KnickmeyerSimon Baron-Cohen
Mar 15, 2011·Frontiers in Neuroendocrinology·Sheri A Berenbaum, Adriene M Beltz
Mar 6, 2007·Hormones and Behavior·Rebecca A Herman, Kim Wallen
Apr 7, 2005·Neuroscience and Biobehavioral Reviews·Celina C C Cohen-BendahanSheri A Berenbaum
Jun 13, 2006·Molecular and Cellular Endocrinology·Jay N GieddGeorge P Chrousos
Jun 21, 2005·Lancet·Deborah P Merke, Stefan R Bornstein
Jun 18, 2002·Best Practice & Research. Clinical Endocrinology & Metabolism·Perrin C White, Phyllis W Speiser
Jun 9, 2015·Best Practice & Research. Clinical Endocrinology & Metabolism·Emma A Webb, Nils Krone
Mar 16, 2017·Korean journal of pediatrics·Jin-Ho Choi, Han-Wook Yoo
Sep 29, 2006·Journal of Child Neurology·Rebecca Christine Knickmeyer, Simon Baron-Cohen
Jul 29, 2008·Journal of Child Neurology·Olga InozemtsevaJorge Juárez
Jun 26, 2007·Nature Neuroscience·Katie M Douglas, David K Bilkey
Nov 8, 2005·Science·Simon Baron-CohenMatthew K Belmonte
May 1, 2019·Archives of Endocrinology and Metabolism·Nermine Hussein AmrNermine Mahmoud Shaker
Nov 17, 2020·Journal of the Endocrine Society·Lauren A HarasymiwKyriakie Sarafoglou

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cachexia & Brown Fat

Cachexia is a condition associated with progressive weight loss due to severe illness. In cancer patients, it is proposed to occur as a result of tumor-induced energy wasting. Several proteins have been implicated in browning and depletion of white adipose tissue. Here is the latest research on cachexia and brown fat.

Cardiac Cachexia

Cardiac cachexia is a syndrome associated with the progressive loss of muscle and fat mass. It most commonly affects patients with heart failure and can significantly decrease the quality of life and survival in these patients. Here is the latest research on cardiac cachexia.